Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Skeletal complications of rheumatoid arthritis.

Literature DB >> 28779302

Skeletal complications of rheumatoid arthritis.

Abstract

Rheumatoid arthritis (RA) is associated with local and systemic inflammation that induces many changes in the skeletal health. Locally, periarticular bone loss and juxta-articular bone erosions may occur while joint ankylosis, generalized bone loss, osteoporosis, and fractures may develop secondary to inflammation. The aim of this narrative review is to summarize the clinical evidence for abnormal skeletal health in RA, the effects of disease modifying anti-rheumatic drugs (DMARDS) on bone health, and the effects of drugs for the prevention or treatment of osteoporosis in the RA population.

Entities: Disease

Keywords: Ankylosis; Bone erosions; Bone fracture; Osteoporosis; Rheumatoid arthritis

Mesh：

Substances：

Year: 2017 PMID： 28779302 DOI： 10.1007/s00198-017-4170-5

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

110 in total

1. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

Authors: E J Kroot; B A de Jong; M A van Leeuwen; H Swinkels; F H van den Hoogen; M van't Hof; L B van de Putte; M H van Rijswijk; W J van Venrooij; P L van Riel
Journal: Arthritis Rheum Date: 2000-08

2. Ankylosis of the wrist bones in patients with rheumatoid arthritis: a study with extremity-dedicated MRI.

Authors: Francesca Barbieri; Giuseppe Zampogna; Dario Camellino; Francesco Paparo; Maurizio Cutolo; Giacomo Garlaschi; Marco A Cimmino
Journal: Clin Exp Rheumatol Date: 2015-11-17 Impact factor: 4.473

3. Opioid Use and Risk of Nonvertebral Fractures in Adults With Rheumatoid Arthritis: A Nested Case-Control Study Using Administrative Databases.

Authors: Francisco A Acurcio; Cristiano S Moura; Sasha Bernatsky; Louis Bessette; Elham Rahme
Journal: Arthritis Rheumatol Date: 2016-01 Impact factor: 10.995

4. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?

Authors: Géraldine Lescaille; Amélie E Coudert; Vanessa Baaroun; Marie-José Javelot; Martine Cohen-Solal; Ariane Berdal; Patrick Goudot; Jean Azérad; Blandine Ruhin; Vianney Descroix
Journal: J Rheumatol Date: 2013-03-15 Impact factor: 4.666

5. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

Authors: W F Lems; M C Lodder; P Lips; J W J Bijlsma; P Geusens; N Schrameijer; C M van de Ven; B A C Dijkmans
Journal: Osteoporos Int Date: 2006-02-03 Impact factor: 4.507

6. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis.

Authors: Nicole C Walsh; Susan Reinwald; Catherine A Manning; Keith W Condon; Ken Iwata; David B Burr; Ellen M Gravallese
Journal: J Bone Miner Res Date: 2009-09 Impact factor: 6.741

7. Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort.

Authors: Raphaèle Seror; Saida Boudaoud; Stephan Pavy; Gaetane Nocturne; Thierry Schaeverbeke; Alain Saraux; Philippe Chanson; Jacques-Eric Gottenberg; Valérie Devauchelle-Pensec; Gabriel J Tobón; Xavier Mariette; Corinne Miceli-Richard
Journal: Sci Rep Date: 2016-01-20 Impact factor: 4.379

8. Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.

Authors: Tomohiro Koga; Akitomo Okada; Takaaki Fukuda; Toshihiko Hidaka; Tomonori Ishii; Yukitaka Ueki; Takao Kodera; Munetoshi Nakashima; Yuichi Takahashi; Seiyo Honda; Yoshiro Horai; Ryu Watanabe; Hiroshi Okuno; Toshiyuki Aramaki; Tomomasa Izumiyama; Osamu Takai; Taiichiro Miyashita; Shuntaro Sato; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Tomoki Origuchi; Hideki Nakamura; Kiyoshi Aoyagi; Katsumi Eguchi; Atsushi Kawakami
Journal: PLoS One Date: 2017-05-15 Impact factor: 3.240

9. Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy.

Authors: Hubert Marotte; Pierre Miossec
Journal: Biologics Date: 2008-12

10. The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis.

Authors: Sylejman Rexhepi; Mjellma Rexhepi; Vjollca Sahatçiu-Meka; Vigan Mahmutaj; Shkumbin Boshnjaku
Journal: Med Arch Date: 2016-04-01

15 in total

Review 1. Cervical spine manifestations of rheumatoid arthritis: a review.

Authors: Nathan A Shlobin; Nader S Dahdaleh
Journal: Neurosurg Rev Date: 2020-10-10 Impact factor: 3.042

2. Incidence and risk factors for vertebral fracture in rheumatoid arthritis: an update meta-analysis.

Authors: Yang Liu; Jun Jiang; Minmin Mo; Xiaohong Sun; Kailong Yu
Journal: Clin Rheumatol Date: 2022-01-10 Impact factor: 2.980

Review 3. Update on imaging of the cervical spine in rheumatoid arthritis.

Authors: Mostafa Ellatif; Ban Sharif; David Baxter; Asif Saifuddin
Journal: Skeletal Radiol Date: 2022-02-10 Impact factor: 2.199

4. Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors: S Jin; E Hsieh; L Peng; C Yu; Y Wang; C Wu; Q Wang; M Li; X Zeng
Journal: Osteoporos Int Date: 2018-03-15 Impact factor: 4.507

5. Osteoporotic fractures in rheumatoid arthritis patients in Argentina: a matched retrospective cohort study.

Authors: Florencia S Pierini; Martin Brom; Marina Scolnik; Valeria Scaglioni; Javier E Rosa; Enrique R Soriano
Journal: Adv Rheumatol Date: 2021-04-07

6. Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis.

Authors: Shangyi Jin; Mengtao Li; Yongfei Fang; Qin Li; Ju Liu; Xinwang Duan; Yi Liu; Rui Wu; Xiaofei Shi; Yongfu Wang; Zhenyu Jiang; Yanhong Wang; Chen Yu; Qian Wang; Xinping Tian; Yan Zhao; Xiaofeng Zeng
Journal: Arthritis Res Ther Date: 2017-11-15 Impact factor: 5.156

7. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors: Tsutomu Takeuchi; Yoshiya Tanaka; Satoshi Soen; Hisashi Yamanaka; Toshiyuki Yoneda; Sakae Tanaka; Takaya Nitta; Naoki Okubo; Harry K Genant; Désirée van der Heijde
Journal: Ann Rheum Dis Date: 2019-04-29 Impact factor: 19.103